CN110644076A - 一种表面接枝重组表皮生长因子纳米纤维的制备方法 - Google Patents
一种表面接枝重组表皮生长因子纳米纤维的制备方法 Download PDFInfo
- Publication number
- CN110644076A CN110644076A CN201910874196.XA CN201910874196A CN110644076A CN 110644076 A CN110644076 A CN 110644076A CN 201910874196 A CN201910874196 A CN 201910874196A CN 110644076 A CN110644076 A CN 110644076A
- Authority
- CN
- China
- Prior art keywords
- epidermal growth
- growth factor
- carboxymethyl chitosan
- nanofiber
- drying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002121 nanofiber Substances 0.000 title claims abstract description 77
- 102000009024 Epidermal Growth Factor Human genes 0.000 title claims abstract description 32
- 101800003838 Epidermal growth factor Proteins 0.000 title claims abstract description 26
- 229940116977 epidermal growth factor Drugs 0.000 title claims abstract description 26
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 229920001661 Chitosan Polymers 0.000 claims abstract description 57
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 49
- 238000002791 soaking Methods 0.000 claims abstract description 36
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 33
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 23
- 238000004108 freeze drying Methods 0.000 claims abstract description 23
- 238000009987 spinning Methods 0.000 claims abstract description 20
- 238000010041 electrostatic spinning Methods 0.000 claims abstract description 19
- 239000002609 medium Substances 0.000 claims abstract description 19
- 238000004880 explosion Methods 0.000 claims abstract description 17
- 238000001035 drying Methods 0.000 claims abstract description 16
- 238000005406 washing Methods 0.000 claims abstract description 11
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 10
- 230000003213 activating effect Effects 0.000 claims abstract description 9
- -1 polyoxyethylene Polymers 0.000 claims abstract description 8
- 239000001963 growth medium Substances 0.000 claims abstract description 4
- 230000007935 neutral effect Effects 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 14
- 230000006196 deacetylation Effects 0.000 claims description 9
- 238000003381 deacetylation reaction Methods 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 239000007789 gas Substances 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 238000001523 electrospinning Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 7
- 208000027418 Wounds and injury Diseases 0.000 abstract description 5
- 230000035755 proliferation Effects 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 210000001339 epidermal cell Anatomy 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 239000012567 medical material Substances 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 17
- 210000002919 epithelial cell Anatomy 0.000 description 7
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 229940116978 human epidermal growth factor Drugs 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 6
- 238000009832 plasma treatment Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000005588 protonation Effects 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 208000028006 Corneal injury Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 102000018386 EGF Family of Proteins Human genes 0.000 description 1
- 108010066486 EGF Family of Proteins Proteins 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F11/00—Chemical after-treatment of artificial filaments or the like during manufacture
- D01F11/04—Chemical after-treatment of artificial filaments or the like during manufacture of synthetic polymers
- D01F11/08—Chemical after-treatment of artificial filaments or the like during manufacture of synthetic polymers of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F11/00—Chemical after-treatment of artificial filaments or the like during manufacture
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/16—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one other macromolecular compound obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds as constituent
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/18—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from other substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Textile Engineering (AREA)
- Inorganic Chemistry (AREA)
- Toxicology (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910874196.XA CN110644076B (zh) | 2019-09-17 | 2019-09-17 | 一种表面接枝重组表皮生长因子纳米纤维的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910874196.XA CN110644076B (zh) | 2019-09-17 | 2019-09-17 | 一种表面接枝重组表皮生长因子纳米纤维的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110644076A true CN110644076A (zh) | 2020-01-03 |
CN110644076B CN110644076B (zh) | 2021-10-26 |
Family
ID=68991927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910874196.XA Active CN110644076B (zh) | 2019-09-17 | 2019-09-17 | 一种表面接枝重组表皮生长因子纳米纤维的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110644076B (zh) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101020077A (zh) * | 2007-03-23 | 2007-08-22 | 四川大学 | 具有组织诱导性的胶原基体表创伤修复膜的制备方法 |
KR20080104932A (ko) * | 2007-05-29 | 2008-12-03 | 금오공과대학교 산학협력단 | 키토산, 생분해성 고분자 및 세포성장인자를 함유하는나노섬유 부직포 |
CN101411878A (zh) * | 2007-10-17 | 2009-04-22 | 中国科学院化学研究所 | 一种在生物降解性材料上锚定生长因子的方法 |
US20090226534A1 (en) * | 2008-03-10 | 2009-09-10 | Marfly 2, L.P. | Bone paste composition |
CN103690991A (zh) * | 2013-12-17 | 2014-04-02 | 李克尊 | 一种软骨修复支架材料的制备方法 |
CN105536055A (zh) * | 2016-01-05 | 2016-05-04 | 暨南大学 | 一种形状记忆型高弹性活性纳米纤维支架及其应用 |
CN105617458A (zh) * | 2016-01-12 | 2016-06-01 | 中国人民解放军第四军医大学 | 一种双向梯度血管内皮生长因子的神经导管制备方法 |
CN105839407A (zh) * | 2016-04-19 | 2016-08-10 | 东南大学 | 一种医用高分子材料纳米纤维的表面生物功能化方法 |
CN107019815A (zh) * | 2016-01-29 | 2017-08-08 | 何伟 | 静电纺丝膜及其制备方法与在制备生物补片中的应用 |
US20180044629A1 (en) * | 2015-02-10 | 2018-02-15 | Lifenet Health | Biologically functional soft tissue scaffolds and implants |
-
2019
- 2019-09-17 CN CN201910874196.XA patent/CN110644076B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101020077A (zh) * | 2007-03-23 | 2007-08-22 | 四川大学 | 具有组织诱导性的胶原基体表创伤修复膜的制备方法 |
KR20080104932A (ko) * | 2007-05-29 | 2008-12-03 | 금오공과대학교 산학협력단 | 키토산, 생분해성 고분자 및 세포성장인자를 함유하는나노섬유 부직포 |
CN101411878A (zh) * | 2007-10-17 | 2009-04-22 | 中国科学院化学研究所 | 一种在生物降解性材料上锚定生长因子的方法 |
US20090226534A1 (en) * | 2008-03-10 | 2009-09-10 | Marfly 2, L.P. | Bone paste composition |
CN103690991A (zh) * | 2013-12-17 | 2014-04-02 | 李克尊 | 一种软骨修复支架材料的制备方法 |
US20180044629A1 (en) * | 2015-02-10 | 2018-02-15 | Lifenet Health | Biologically functional soft tissue scaffolds and implants |
CN105536055A (zh) * | 2016-01-05 | 2016-05-04 | 暨南大学 | 一种形状记忆型高弹性活性纳米纤维支架及其应用 |
CN105617458A (zh) * | 2016-01-12 | 2016-06-01 | 中国人民解放军第四军医大学 | 一种双向梯度血管内皮生长因子的神经导管制备方法 |
CN107019815A (zh) * | 2016-01-29 | 2017-08-08 | 何伟 | 静电纺丝膜及其制备方法与在制备生物补片中的应用 |
CN105839407A (zh) * | 2016-04-19 | 2016-08-10 | 东南大学 | 一种医用高分子材料纳米纤维的表面生物功能化方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110644076B (zh) | 2021-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Napavichayanun et al. | Interaction and effectiveness of antimicrobials along with healing-promoting agents in a novel biocellulose wound dressing | |
CN113509590B (zh) | 外泌体联合透明质酸的伤口敷料及其制备方法和应用 | |
CN104857569A (zh) | 一种丝素与氧化石墨烯复合支架材料的制备方法 | |
CN107551311B (zh) | 一种可控药物释放的取向多孔复合电纺纤维膜及其制备方法和应用 | |
WO2015103988A1 (zh) | 一种药用敷料水凝胶复合织物及其制备方法和应用 | |
CN107737364A (zh) | 一种创伤敷料及其制备方法 | |
CN115487337A (zh) | 一种皮肤修复用敷料贴及其制备方法 | |
US10456410B2 (en) | Hydrogen sulfide (H2S) releasing donor compound for dermal wound regeneration | |
Shang et al. | A bioactive composite hydrogel dressing that promotes healing of both acute and chronic diabetic skin wounds | |
CN105944135B (zh) | 一种复合海绵及其制备方法 | |
Hou et al. | Acceleration of healing in full-thickness wound by chitosan-binding bFGF and antimicrobial peptide modification chitosan membrane | |
Wang et al. | Multi-functional nanofilms capable of angiogenesis, near-infrared-triggered anti-bacterial activity and inflammatory regulation for infected wound healing | |
CN110644076B (zh) | 一种表面接枝重组表皮生长因子纳米纤维的制备方法 | |
CN110496247B (zh) | 一种骨再生材料的制备方法 | |
CN110629321B (zh) | 一种抗凝血溶纤纳米纤维材料的制备方法 | |
CN114984295A (zh) | 多孔纳米医用敷料及其制备方法 | |
CN115177778A (zh) | 一种复合型伤口敷料、制备方法及应用 | |
CN114921105A (zh) | 一种电响应型丝素蛋白材料及其制备方法和电响应型丝素蛋白微针 | |
CN112569409A (zh) | 一种防止肌腱粘连的羊膜复合材料 | |
Wang et al. | Ligand‐selective targeting of macrophage hydrogel elicits bone immune‐stem cell endogenous self‐healing program to promote bone regeneration | |
CN110507846B (zh) | 一种长效抗菌促愈合角蛋白敷料的制备方法 | |
Kim et al. | Liquid-type plasma-controlled in situ crosslinking of silk-alginate injectable gel displayed better bioactivities and mechanical properties | |
CN112979999A (zh) | 生物大分子及改性埃洛石复合水凝胶及其制备和应用 | |
CN112057667A (zh) | 一种可降解吸收的生物止血材料 | |
Deng et al. | Chondroitin sulfate/silk fibroin hydrogel incorporating graphene oxide quantum dots with photothermal-effect promotes type H vessel-related wound healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230512 Address after: Room 801, 85 Kefeng Road, Huangpu District, Guangzhou City, Guangdong Province Patentee after: Guangzhou Dayu Chuangfu Technology Co.,Ltd. Address before: 226019 Jiangsu city of Nantong province sik Road No. 9 Patentee before: NANTONG University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240612 Address after: 239200 room 109, No. 1 Anle street, Xin'an Town, Lai'an county, Chuzhou City, Anhui Province Patentee after: Chen Sisi Country or region after: China Address before: Room 801, 85 Kefeng Road, Huangpu District, Guangzhou City, Guangdong Province Patentee before: Guangzhou Dayu Chuangfu Technology Co.,Ltd. Country or region before: China |